Please wait while the transcript is being prepared...
0:00
I will talk today about
the Biotech and Pharma
business and how unique
this business have been since
a while and how this
business evolved overtime.
There is a lot of
history that impacted
the changes in
practices in Biotech
and Pharma and we are now at
that stage of these dynamics
in the marketplace.
Eventually, these
changes will not
only affect the health system
in general and the patients, but
will also have impact
on how these
pharmaceutical companies
compete with each other in
different markets and
different aspects.
0:39
My name is Radi Haloub.
I'm an associate professor at
University College London (UCL).
I'm leading the Biotech
and Pharmaceutical
management program
at the Global Business
School for Health.
I've worked in the industry,
launched many drugs
in different markets
and I'm an academic
and practitioner.
0:58
The aim of this
session is to define
the business mindset for
pharma and Biotech and
the historical changes over
the years and how these
changes impacted the business,
impacted the regulations, and
impacted eventually
patients and healthcare.
I will identify the components
of the business in
terms of human,
regulatory, machine, global
and financial aspects.
That will add you into
the industry from
different angles.
1:29
The Biotech and
Pharmaceutical business.
The relationship between
Biotech companies and
Pharmaceutical
companies are quite
important to identify
at this stage.
Pharmaceutical companies
can be generics can be
principles and Biotech companies
can be Biotech and biosimilar,
but it's always about how
these relationships between
the two industries
or the two types
of companies would impact
each other's business.
Biotech is a new industry
when it's compared to
pharmaceutical companies,
they can substitute
pharmaceuticals in
the future, pharmaceuticals
as it stands now,
they are the engines of
the healthcare sector.
Both of them require
huge investments.
Both of them they
invest in the R&D and
they are basically
very profitable,
but the Biotech they invest in
blue ocean and they
are trying just to be
pioneer and innovative
in different aspects of
the business whereas
Pharmaceutical,
they are hypercompetitive.
They substitute
each other and they
outsource when it's compared
to Biotech companies.
How the Biotech companies
and Pharmaceutical companies
interact with each other in
the marketplace
is very important
for us to understand
because that is
basically where the history will
going to be written and in
the future will define
the directions of both
type of industries.
